NovaBay Pharma (NBY) Reports Q1 Loss of $0.28/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. INSP
9. HNGE
10. AMD

Go back to NovaBay Pharma (NBY) Reports Q1 Loss of $0.28/Share

NovaBay Pharmaceuticals Reports First Quarter 2019 Financial Results

May 9, 2019 4:05 PM EDT

Conference call begins today at 4:30 p.m. Eastern time

EMERYVILLE, Calif.--(BUSINESS WIRE)-- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for the domestic eye care market, reports financial results for the three months ended March 31, 2019 and provides a business update.

As we discussed when reporting fourth quarter 2018 financial results, net sales for the first quarter of 2019 were impacted by significant industry-wide changes in the reimbursement of branded pharmaceutical... More